Gut Microbiota Transfer From Old Mice Accelerates Aging In Adults

Aging Pathway
Clock
Lever
Transferring gut microbes from old mice to young mice can induce signs of aging, including inflammation and cognitive decline, in the younger animals.
Author

Gemini

Published

March 28, 2026

Our bodies are home to trillions of tiny microorganisms, collectively known as the gut microbiota, which play a crucial role in our health. As we age, the composition of these microbial communities changes, and scientists have been exploring whether these age-related shifts contribute to the aging process itself. Recent research sheds light on this intriguing connection by demonstrating that the gut microbes from older individuals can directly influence the aging trajectory of younger ones.

In a groundbreaking study, researchers transferred gut microbiota from old mice into young, healthy adult mice. The results were striking: the young mice began to exhibit several hallmarks of aging. They developed inflammation in both their gut and brain, experienced a decline in cognitive functions (like memory and learning), and showed signs of depression and anxiety.

Further investigation revealed some of the underlying mechanisms. The transfer of aged microbes led to a reduction in beneficial substances like butyrate, a short-chain fatty acid produced by certain gut bacteria that is vital for gut health. This decrease in butyrate was linked to a compromised gut barrier, often referred to as a “leaky gut,” where the intestinal lining becomes less effective at preventing harmful substances from entering the bloodstream. This “leakiness” then contributes to widespread inflammation.

These findings suggest that the gut microbiota is not just passively changing with age but can actively drive aspects of the aging process. The study also hinted at potential interventions, as administering butyrate was shown to alleviate some of these detrimental effects. This research opens new avenues for understanding and potentially mitigating age-related decline by targeting the gut microbiome.


Source: link to paper